Suggestions
Saad Sirop Kenderian
Physician, Scientist, Innovator Hematology, Oncology, Bone Marrow Transplant, Immunology, Molecular Medicine, Regenerative Medicine
Saad Sirop Kenderian is a prominent figure in the field of cancer research and treatment, currently serving as the Co-Leader of Cancer Immunology and Immunotherapy at the Mayo Clinic Comprehensive Cancer Center. His work focuses on advancing immunotherapy techniques, particularly in the context of CAR-T cell therapy, which is a groundbreaking approach in treating various cancers.
Education and Certifications
- Medical Degree: MBChB with First Honors from the University of Baghdad School of Medicine (2003).
- Board Certifications:
- American Board of Internal Medicine (2009)
- Medical Oncology (2013)
- Hematology (2013)
- Additional Certification: Educational Committee for Foreign Medical Graduates Certificate (2005).
Research and Contributions
Kenderian has made significant contributions to understanding and improving chimeric antigen receptor (CAR) T-cell therapies. His research has identified critical checkpoints like PD1 and TIM3 that limit the efficacy of these therapies in leukemia, leading to advancements in treatment protocols. He has received multiple awards for his research, including:
- Abstract Achievement Award from the American Society of Hematology (2015).
- Best Abstract Award from the American Society for Blood and Marrow Transplantation (2016).
- NCCN Young Investigator Award (2017).
Professional Recognition
Throughout his career, Kenderian has been recognized for his exceptional contributions to medicine and research. He has received numerous accolades, including:
- Outstanding Hem/Onc Fellow Achievement Award from Mayo Clinic (2013).
- Chief Fellow Award from Mayo Clinic (2013).
- New Investigator Award from Mayo Clinic (2018).
Current Role and Impact
In his role at Mayo Clinic, Kenderian leads initiatives aimed at enhancing cancer treatment through innovative immunological strategies. He is actively involved in mentoring young scientists and promoting equitable access to cancer therapies. His commitment to research and education positions him as a key contributor to the ongoing advancements in cancer care.
Kenderian's LinkedIn profile reflects his extensive network and ongoing engagement with the scientific community, showcasing his dedication to collaboration and knowledge sharing in the field of cancer immunology.1
Highlights
ISCT, International Society for Cell & Gene Therapy #ISCT2024 | Vancouver, Canada Productive discussin in a round table panel on translation of discoveries to the clinic Mayo Clinic. Thanks to Julie G. Allickson, PhD for organizing the event. William Faubion David Lott Saranya Wyles, M.D., Ph.D. Claudia Manriquez Roman presented the development of novel #cart cell therapy in thyroid cancers to overcome #cart resistance. The most joyful part of the meeting is always to spend time with our lab family!
Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic - 2024 commencement. Congratulation to 2024 PhD and MD graduates! Had the the distinct honor of hooding and celebrating the graduation of our PhD student and #cart super star Claudia Manriquez Roman! Grateful to our students to recieve the Mayo Clinic enterprise 2024 outstanding mentor award!
https://lnkd.in/gSrU4QwJ
